Skip to main content
Jeffery Kutok, MD, Pathology, Boston, MA

JefferyLorneKutokMD

Pathology • Boston, MA

Hematopathology, Anatomic Pathology, Clinical Pathology

Associate Professor of Pathology, Brigham and Women's Hospital

Join to view full profile

Are you Dr. Kutok?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 51 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

  • Office

    75 Francis Street Amory 3
    Brigham And Womens Hospital Department Of Pathology
    Boston, MA 02115
    Phone+1 617-732-5714
  • Is this information wrong?

Summary

  • Dr. Jeffery Kutok, MD is a board certified pathologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is an Associate Professor of Pathology at Brigham and Women's Hospital.

Education & Training

  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 1995 - 1999
  • Stony Brook University Health Sciences Center School of Medicine
    Stony Brook University Health Sciences Center School of MedicineClass of 1995
  • Brigham and Women's Hospital
    Brigham and Women's HospitalFellowship, Hematopathology

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1999 - 2018
  • American Board of Pathology Anatomic Pathology
  • American Board of Pathology Hematology

Publications & Presentations

PubMed

Press Mentions

  • Epizyme Presents Preclinical Data and Phase 1/1b Trial Design on the Company’s SETD2 Inhibitor, EZM0414, at the 2021 ASH Annual Meeting
    Epizyme Presents Preclinical Data and Phase 1/1b Trial Design on the Company’s SETD2 Inhibitor, EZM0414, at the 2021 ASH Annual MeetingDecember 11th, 2021
  • Epizyme Hires Kutok as CSO to Find New Uses for Tazverik
    Epizyme Hires Kutok as CSO to Find New Uses for TazverikMarch 20th, 2020
  • Epizyme Appoints Jeffery Kutok, M.D., Ph.D., as Chief Scientific Officer
    Epizyme Appoints Jeffery Kutok, M.D., Ph.D., as Chief Scientific OfficerMarch 20th, 2020
  • Join now to see all

Grant Support

  • Tissue Banking And Molecular AssessmentNational Cancer Institute2006–2010

Dr. Jeffery Kutok, Dr. Jeffery Kutok, MD, Dr. J Kutok, Dr. Jeffery Lorne Kutok